Eszter Kassa

Eszter Kassa

Auto-generated profile, based on publicly available information

Eszter Kassa

Department of Chemistry - BMC, Uppsala University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
FMFilip Mihalič
Filip Mihalič
CBCaroline Benz
Caroline Benz
EKEszter Kassa
Eszter Kassa
RLRichard Lindqvist
Richard Lindqvist
LSLeandro Simonetti
Leandro Simonetti
Ylva IvarssonYlva Ivarsson
Ylva Ivarsson
The virus life cycle depends on host-virus protein-protein interactions, which often involve a disordered protein region binding to a folded protein domain. Here, we used proteomic peptide phage display (ProP-PD) to identify peptides from the intrinsically disordered regions of the human proteome that bind to folded protein domains encoded by the SARS-CoV-2 genome. Eleven folded domains of SARS-CoV-2 proteins were found to bind 281 peptides from human proteins, and affinities of 31 interactions involving eight SARS-CoV-2 protein domains were determined (KD ∼ 7-300 μM). Key specificity residues of the peptides were established for six of the interactions. Two of the peptides, binding Nsp9 and Nsp16, respectively, inhibited viral replication. Our findings demonstrate how high-throughput peptide binding screens simultaneously identify potential host-virus interactions and peptides with antiviral properties. Furthermore, the high number of low-affinity interactions suggest that overexpression of viral proteins during infection may perturb multiple cellular pathways.

19 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
FMFilip Mihalic
Filip Mihalic
LSLeandro Simonetti
Leandro Simonetti
GGGirolamo Giudice
Girolamo Giudice
MSMarie Rubin Sander
Marie Rubin Sander
RLRichard Lindqvist
Richard Lindqvist
Ylva IvarssonYlva Ivarsson
Ylva Ivarsson
SUMMARY: Viruses mimic host short linear motifs (SLiMs) to hijack and deregulate cellular functions. Studies of motif-mediated interactions therefore provide insight into virus-host dependencies, and reveal targets for therapeutic intervention. Here, we describe the pan-viral discovery of 1,712 SLiM-based virus-host interactions using a phage peptidome tiling the intrinsically disordered protein regions of 229 RNA viruses. We find mimicry of host SLiMs to be a ubiquitous viral strategy, reveal novel host proteins hijacked by viruses, and identify cellular pathways frequently deregulated by viral motif mimicry. Using structural and biophysical analyses, we show that viral mimicry-based interactions have similar binding strength and bound conformations as endogenous interactions. Finally, we establish polyadenylate-binding protein 1 as a potential target for broad-spectrum antiviral agent development. Our platform enables rapid discovery of mechanisms of viral interference and the identification of potential therapeutic targets which can aid in combating future epidemics and pandemics.

19 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
EKEszter Kassa
Eszter Kassa
SJSara Jamshidi
Sara Jamshidi
FMFilip Mihalič
Filip Mihalič
LSLeandro Simonetti
Leandro Simonetti
JKJohanna Kliche
Johanna Kliche
Ylva IvarssonYlva Ivarsson
Ylva Ivarsson
Low affinity and transient protein-protein interactions, such as short linear motif (SLiM)-based interactions, require dedicated experimental tools for discovery and validation. Here, we evaluated and compared biotinylated peptide pulldown and protein interaction screen on peptide matrix (PRISMA) coupled to mass-spectrometry (MS) using a set of peptides containing interaction motifs. Eight different peptide sequences that engage in interactions with three distinct protein domains (KEAP1 Kelch, MDM2 SWIB, and TSG101 UEV) with a wide range of affinities were tested. We found that peptide pulldown can be an effective approach for SLiM validation, however, parameters such as protein abundance and competitive interactions can prevent the capture of known interactors. The use of tandem peptide repeats improved the capture and preservation of some interactions. When testing PRISMA, it failed to provide comparable results for a model peptide that successfully pulled down a known interactor using biotinylated peptide pulldown. Overall, in our hands, we find that albeit more laborious, biotin-peptide pulldown was more successful in terms of validation of known interactions. Our results highlight that the tested affinity-capture MS-based methods for validation of SLiM-based interactions from cell lysates are suboptimal, and we identified parameters for consideration for method development.